• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

530.11 +3.04 (+0.58%)
Streaming Delayed Price Updated: 1:42 PM EDT, Jul 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 93,463
Open 523.23
Bid (Size) 529.64 (40)
Ask (Size) 530.58 (120)
Prev. Close 527.07
Today's Range 519.01 - 532.12
52wk Range 272.12 - 609.35
Shares Outstanding 44,891,523
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
United Therapeutics Corporation Announces Appointment of Victor Dzau to its Board of Directors
Today 6:30 EDT
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August 5, 2026
July 22, 2026
From United Therapeutics Corporation
Via Business Wire

Performance

YTD
+6.7%
+6.7%
1 Month
-1.5%
-1.5%
3 Month
-7.7%
-7.7%
6 Month
+12.8%
+12.8%
1 Year
+78.0%
+78.0%

More News

Read More
News headline image
United Therapeutics Corporation Acquires Thymmune Therapeutics
July 02, 2026
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion
June 29, 2026
From United Therapeutics Corporation
Via Business Wire
News headline image
Therapeutics Stocks Q1 Recap: Benchmarking Biogen (NASDAQ:BIIB)
June 22, 2026
Via StockStory
Topics Artificial Intelligence
United Therapeutics (NASDAQ:UTHR) Shares Dip After Q1 2026 Earnings Miss ↗
May 06, 2026
Via Chartmill
News headline image
Q1 Earnings Outperformers: United Therapeutics (NASDAQ:UTHR) And The Rest Of The Therapeutics Stocks
June 21, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
These 3 Stocks Lowered Their Share Counts Drastically in Q1 ↗
June 09, 2026
Via MarketBeat
News headline image
1 Cash-Producing Stock with Exciting Potential and 2 We Ignore
June 03, 2026
Via StockStory
Topics Energy
News headline image
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year ↗
May 30, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
2 Mid-Cap Stocks on Our Buy List and 1 We Turn Down
May 29, 2026
Via StockStory
Topics Credit Cards
News headline image
United Therapeutics Corporation to Present at the Jefferies Global Healthcare Conference
May 27, 2026
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026
May 18, 2026
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026
May 17, 2026
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial
May 15, 2026
From United Therapeutics Corporation
Via Business Wire
News headline image
5 Insightful Analyst Questions From United Therapeutics’s Q1 Earnings Call
May 13, 2026
Via StockStory
Topics Earnings
News headline image
United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference
May 12, 2026
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026
May 11, 2026
From United Therapeutics Corporation
Via Business Wire
News headline image
UTHR Q1 Deep Dive: Pipeline Advances and Product Launches Dominate Outlook
May 07, 2026
Via StockStory
News headline image
UTHR Q1 2026 Earnings Transcript ↗
May 06, 2026
Via The Motley Fool
News headline image
United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings
May 06, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
United Therapeutics Corporation Reports First Quarter 2026 Financial Results
May 06, 2026
From United Therapeutics Corporation
Via Business Wire
News headline image
MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
May 06, 2026
From MannKind
Via GlobeNewswire
News headline image
United Therapeutics (UTHR) Q1 Earnings Report Preview: What To Look For
May 04, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors
April 29, 2026
From United Therapeutics Corporation
Via Business Wire

Frequently Asked Questions

Is United Therapeutics Corporation - Common Stock publicly traded?
Yes, United Therapeutics Corporation - Common Stock is publicly traded.
What exchange does United Therapeutics Corporation - Common Stock trade on?
United Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for United Therapeutics Corporation - Common Stock?
The ticker symbol for United Therapeutics Corporation - Common Stock is UTHR on the Nasdaq Stock Market
What is the current price of United Therapeutics Corporation - Common Stock?
The current price of United Therapeutics Corporation - Common Stock is 530.11
When was United Therapeutics Corporation - Common Stock last traded?
The last trade of United Therapeutics Corporation - Common Stock was at 07/23/26 01:42 PM ET
What is the market capitalization of United Therapeutics Corporation - Common Stock?
The market capitalization of United Therapeutics Corporation - Common Stock is 23.80B
How many shares of United Therapeutics Corporation - Common Stock are outstanding?
United Therapeutics Corporation - Common Stock has 24B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap